Logo image of ELWS

EARLYWORKS CO LTD-ADR (ELWS) Stock Fundamental Analysis

NASDAQ:ELWS - Nasdaq - US27030F2020 - ADR - Currency: USD

1.93  -0.03 (-1.53%)

Fundamental Rating

2

Taking everything into account, ELWS scores 2 out of 10 in our fundamental rating. ELWS was compared to 81 industry peers in the Professional Services industry. The financial health of ELWS is average, but there are quite some concerns on its profitability. ELWS does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year ELWS has reported negative net income.
In the past year ELWS has reported a negative cash flow from operations.
ELWS Yearly Net Income VS EBIT VS OCF VS FCFELWS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 -200M -400M -600M

1.2 Ratios

Looking at the Return On Assets, with a value of -90.54%, ELWS is doing worse than 95.06% of the companies in the same industry.
With a Return On Equity value of -157.56%, ELWS is not doing good in the industry: 88.89% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -90.54%
ROE -157.56%
ROIC N/A
ROA(3y)-74.3%
ROA(5y)N/A
ROE(3y)-128.99%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ELWS Yearly ROA, ROE, ROICELWS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 -50 -100 -150

1.3 Margins

Looking at the Gross Margin, with a value of 82.54%, ELWS belongs to the top of the industry, outperforming 92.59% of the companies in the same industry.
ELWS's Gross Margin has declined in the last couple of years.
ELWS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 82.54%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.19%
GM growth 5YN/A
ELWS Yearly Profit, Operating, Gross MarginsELWS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 -200 -400 -600 -800

5

2. Health

2.1 Basic Checks

ELWS does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ELWS has been increased compared to 1 year ago.
ELWS has a better debt/assets ratio than last year.
ELWS Yearly Shares OutstandingELWS Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 5M 10M 15M
ELWS Yearly Total Debt VS Total AssetsELWS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

ELWS has an Altman-Z score of -4.95. This is a bad value and indicates that ELWS is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -4.95, ELWS is not doing good in the industry: 91.36% of the companies in the same industry are doing better.
A Debt/Equity ratio of 0.15 indicates that ELWS is not too dependend on debt financing.
The Debt to Equity ratio of ELWS (0.15) is better than 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF N/A
Altman-Z -4.95
ROIC/WACCN/A
WACC1.83%
ELWS Yearly LT Debt VS Equity VS FCFELWS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 200M -200M 400M -400M

2.3 Liquidity

ELWS has a Current Ratio of 2.75. This indicates that ELWS is financially healthy and has no problem in meeting its short term obligations.
ELWS has a Current ratio of 2.75. This is amongst the best in the industry. ELWS outperforms 85.19% of its industry peers.
ELWS has a Quick Ratio of 2.75. This indicates that ELWS is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of ELWS (2.75) is better than 86.42% of its industry peers.
Industry RankSector Rank
Current Ratio 2.75
Quick Ratio 2.75
ELWS Yearly Current Assets VS Current LiabilitesELWS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 200M 400M 600M

1

3. Growth

3.1 Past

ELWS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 10.26%, which is quite good.
The Revenue has grown by 197.43% in the past year. This is a very strong growth!
ELWS shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -6.04% yearly.
EPS 1Y (TTM)10.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%10.44%
Revenue 1Y (TTM)197.43%
Revenue growth 3Y-6.04%
Revenue growth 5YN/A
Sales Q2Q%285.14%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ELWS Yearly Revenue VS EstimatesELWS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 100M 200M 300M 400M

0

4. Valuation

4.1 Price/Earnings Ratio

ELWS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ELWS Price Earnings VS Forward Price EarningsELWS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ELWS Per share dataELWS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 -1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for ELWS!.
Industry RankSector Rank
Dividend Yield N/A

EARLYWORKS CO LTD-ADR

NASDAQ:ELWS (6/18/2025, 10:41:25 AM)

1.93

-0.03 (-1.53%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.8%
Inst Owner Change-62.95%
Ins Owners36.23%
Ins Owner ChangeN/A
Market Cap5.82M
AnalystsN/A
Price TargetN/A
Short Float %2.32%
Short Ratio0.29
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.59
P/FCF N/A
P/OCF N/A
P/B 2.55
P/tB 2.55
EV/EBITDA N/A
EPS(TTM)-1.2
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.9
FCFYN/A
OCF(TTM)-0.9
OCFYN/A
SpS0.54
BVpS0.76
TBVpS0.76
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -90.54%
ROE -157.56%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 82.54%
FCFM N/A
ROA(3y)-74.3%
ROA(5y)N/A
ROE(3y)-128.99%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.19%
GM growth 5YN/A
F-Score6
Asset Turnover0.41
Health
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 31.03%
Cap/Sales 0.14%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.75
Quick Ratio 2.75
Altman-Z -4.95
F-Score6
WACC1.83%
ROIC/WACCN/A
Cap/Depr(3y)185.81%
Cap/Depr(5y)N/A
Cap/Sales(3y)1.3%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)10.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%10.44%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)197.43%
Revenue growth 3Y-6.04%
Revenue growth 5YN/A
Sales Q2Q%285.14%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-0.49%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y1.79%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y1.47%
OCF growth 3YN/A
OCF growth 5YN/A